Impact Factor
3.96
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.39
992 total citations
h5-index
40
h5 depth signal
Cited share
80.2%
158 of 197
Total citations
992
Citation footprint
Metric signal
5.97
External metric anchor
Self-citation
1.1%
11 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
357
Germany
135
United Kingdom
117
France
97
Italy
91
Citing Fields of Research
Neuromuscular Disorders
255
Neurodegenerative Disorders
230
Brain Neurological Disorders
180
Nervous System Disorders
123
Musculoskeletal Disorders
99
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,541
Articles tracked across the journal lifetime
Indexed publication set
197
158 cited publications
Last 12 months
79
7.9 publications/month
Open access share
27.8%
22 OA publications in the last year
Leading citing country
United States
357 citing publications
Leading citing field
Neuromuscular Disorders
255 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v6n5,Oct. 1993-
v6n5,Oct. 1993-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neuromuscular Disorders
Neurodegenerative Disorders
Brain Neurological Disorders
Migraines & Headaches
Postural Control
Brain Imaging
Issuing & Sponsoring Bodies
Contributor
World Federation of Neurology. Research Group on Neurological Education
Broad Categories
Neurology
Neurodegenerative Disorders
Neuromuscular Disorders
Migraines & Headaches
Brain Imaging
Brain Neurological Disorders
MeSH Descriptors
Nervous System Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/wco.0000000000001517
Open DOI
The electrical life of cancer: cancer neuroscience from circuits to patient care
Purpose of review: Cancer neuroscience has evolved from a predominantly preclinical, mechanistic discipline into a clinically relevant framework for understanding and treating patients with brain malignancies. This review synthesizes rec...
02
DOI 10.1097/wco.0000000000001519
Open DOI
Novel therapies for glioblastoma
Purpose of review: Glioblastoma is the most aggressive and treatment-resistant primary brain tumor in adults. Given its clinical severity and biological complexity, research efforts are focused on understanding and targeting intratumoral...
03
DOI 10.1097/wco.0000000000001523
Open DOI
Management of seizures in patients with brain tumors
Purpose of review: Discoveries relating to the cancer neuroscience of gliomas have reframed brain tumor-related epilepsy (BTRE) as the product of reciprocal interactions at the neural–tumor interface. This framework provides the rational...
04
DOI 10.1097/wco.0000000000001516
Open DOI
Editorial introduction
Was not provided for this article.
05
DOI 10.1097/wco.0000000000001514
Open DOI
Myopathies in the therapeutic era: measurement as the rate-limiting step
Was not provided for this article.
06
DOI 10.1097/wco.0000000000001512
Open DOI
Recent advances in adult-onset disorders of muscle lipid metabolism
Purpose of review: To summarize recent advances in adult-onset disorders of muscle lipid metabolism, with particular emphasis on fatty acid β-oxidation disorders (FAODs), multiple acyl-CoA dehydrogenase deficiency (MADD) and MADD-like di...
07
DOI 10.1097/wco.0000000000001509
Open DOI
Myotonic dystrophy type 1 – updates on mechanisms of multisystemic manifestations, genetically targeted therapeutics, and preparing for a postapproval world
Purpose of review: Myotonic dystrophy type (DM1) is the most prevalent muscular dystrophy and manifests throughout the lifespan with signs and symptoms in all major organ systems. There are significant updates on therapeutic development ...
08
DOI 10.1097/wco.0000000000001508
Open DOI
Recent progress in emerging therapeutics and evaluation of oculopharyngeal muscular dystrophy
Purpose of review: Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, genetic, neuromuscular disorder causing progressive ptosis, dysphagia and proximal muscle weakness. This review highlights emerging therapeutic strategies and ...
09
DOI 10.1097/wco.0000000000001513
Open DOI
Biomarkers in facioscapulohumeral muscular dystrophy
Purpose of review: Facioscapulohumeral muscular dystrophy is one of the most frequent myopathies. Its clinical presentation and genetic background are unique. FSHD needs reliable and measurable biomarkers to monitor the disease and asses...
10
DOI 10.1097/wco.0000000000001510
Open DOI
A global comparison of clinical guidelines for the diagnosis and management of migraine: similarities, differences, and gaps
Purpose of review: To compare international clinical guidelines for migraine diagnosis and management, identifying consensus, differences, and gaps. Recent findings: Assessed guideline repositories and society websites from 2012 to 2025 ...
Bibliographical & Catalog Notes
Also issued online.
Sponsored by the World Federation of Neurology Research Group on Neurological Education.
Continues: Current opinion in neurology and neurosurgery.
Vol. 8, no. 1 (1995)19950518 Notice not published Printed on acid-free paper